Chronic Expression of a Clinical SFTPC Mutation Causes Murine Lung Fibrosis with Idiopathic Pulmonary Fibrosis Features
Authors:
- 1 April 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Respiratory Cell and Molecular Biology
- Vol. 68 (4) , 358-365
Abstract
Idiopathic pulmonary fibrosis (IPF) is a chronic progressive fibrotic interstitial lung disease. A barrier to developing more effective therapies for IPF is the dearth of preclinical models that recapitulate the early pathobiology of this disease. Intratracheal bleomycin, the conventional preclinical murine model of IPF, fails to reproduce the intrinsic dysfunction to the alveolar epithelial type 2 cell (AEC2) that is believed to be a proximal event in the pathogenesis of IPF. Murine fibrosis models based on SFTPC (Surfactant Protein C gene) mutations identified in patients with interstitial lung disease cause activation of the AEC2 unfolded protein response and endoplasmic reticulum stress—an AEC2 dysfunction phenotype observed in IPF. Although these models achieve spontaneous fibrosis, they do so with precedent lung injury and thus are challenged to phenocopy the general clinical course of patients with IPF—gradual progressive fibrosis and loss of lung function. Here, we report a refinement of a murine Sftpc mutation model to recapitulate the clinical course, physiological impairment, parenchymal cellular composition, and biomarkers associated with IPF. This platform provides the field with an innovative model to understand IPF pathogenesis and index preclinical therapeutic candidates.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (1K08HL150226)
- Department of Veterans Affairs, Australian Government (2I01BX001176-10)
- Bristol Myers Squibb IDEAL Consortium 2.0
- Pulmonary Fibrosis Foundation
- Parker B Francis Foundation
- National Heart, Lung, and Blood Institute (1K08HL150226)
- Department of Veterans Affairs, Australian Government (2I01BX001176-10)
- Bristol Myers Squibb IDEAL Consortium 2.0
- Pulmonary Fibrosis Foundation
- Parker B Francis Foundation
This publication has 36 references indexed in Scilit:
- Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organsNature Medicine, 2013
- Animal Models of Fibrotic Lung DiseaseAmerican Journal of Respiratory Cell and Molecular Biology, 2013
- Endoplasmic reticulum stress as a pro-fibrotic stimulusBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2013
- The Alveolar Epithelium Determines Susceptibility to Lung Fibrosis in Hermansky-Pudlak SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Endoplasmic reticulum stress enhances fibrotic remodeling in the lungsProceedings of the National Academy of Sciences, 2011
- Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosisAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2010
- Bronchoalveolar lavage in idiopathic pulmonary fibrosis: What does it tell us?Respiratory Medicine, 2010
- Epithelial Endoplasmic Reticulum Stress and Apoptosis in Sporadic Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Classification and Natural History of the Idiopathic Interstitial PneumoniasProceedings of the American Thoracic Society, 2006
- Aberrant lung structure, composition, and function in a murine model of Hermansky-Pudlak syndromeAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2003